Suppr超能文献

Use of gelatinized maca (lepidium peruvianum) in early postmenopausal women.

作者信息

Meissner H O, Kapczynski W, Mscisz A, Lutomski J

机构信息

Faculty of Health Studies, Charles Sturt University & TTD International Pty Ltd, Sydney, Australia;

出版信息

Int J Biomed Sci. 2005 Jun;1(1):33-45.

Abstract

OBJECTIVE

This double-blind, placebo-corrected clinical pilot study was aimed at assessing the use of hypocotyls of cruciferous Andean plant Maca (Lepidium peruvianum Chacon), in alleviating symptoms of menopausal discomfort experienced by women in early post menopause as measured by profiles of serum hormones: Luteinizing Hormone (LH), Follicle-stimulating Hormone (FSH), Estrogen (E2) and Progesterone (PG) and as assessed by Greene's Menopausal Index.

DESIGN

Study was conducted on 20 Caucasian healthy early-postmenopausal women volunteers during the three months period (Trial I) and on eight women during nine months period (Trial II). Hormone levels were determined in blood with a simultaneous assessment of menopausal index at the start of study, after one month use of placebo, and after two and eight months administration of 2g gelatinized Maca root powder (Maca-GO) in the form of two 500mg hard gel capsules, twice daily.

RESULTS

In comparison to placebo, after both, two and eight months administration of Maca-GO capsules to EPMW, level of FSH significantly (P<0.05) decreased with a simultaneous significant (P<0.05) increase in the LH level, resulting in significant (P<0.05) increase in both E2 and PG, after eight months of Maca-GO treatment only. There was a significant (P<0.05) placebo effect resulting in an elevated PG level after one month administration of placebo capsules. Changes in hormone levels was accompanied by substantially-reduced feeling of discomfort associated with menopause, although, there was a distinctive, positive placebo effect as judged by responses to Greene's questionnaire.

CONCLUSIONS

It is reasonable to suggest that Maca-GO when used in EPMW, depending on the length of use, was acting as a toner of hormonal processes as reflected by decrease in FSH and increased LH secretion, which stimulated production of both ovarian hormones, E2 and PG and resulted in a substantial reduction of menopausal discomfort felt by women participating in the study, with a distinctive placebo effect, thus, fully justifying further, more complex study on effectiveness of Maca-GO as a reliable alternative to HRT program.

摘要

相似文献

7
Maca reduces blood pressure and depression, in a pilot study in postmenopausal women.
Climacteric. 2015 Feb;18(1):69-78. doi: 10.3109/13697137.2014.929649. Epub 2014 Aug 7.
9
Lepidium meyenii (Maca) enhances the serum levels of luteinising hormone in female rats.
J Ethnopharmacol. 2014 Feb 3;151(2):897-902. doi: 10.1016/j.jep.2013.11.058. Epub 2013 Dec 11.
10
Maca (Lepidium meyenii) for treatment of menopausal symptoms: A systematic review.
Maturitas. 2011 Nov;70(3):227-33. doi: 10.1016/j.maturitas.2011.07.017. Epub 2011 Aug 15.

引用本文的文献

1
as a Source of Compounds with Anticancer and Cosmetic Applications.
Int J Mol Sci. 2024 Oct 8;25(19):10816. doi: 10.3390/ijms251910816.
4
5
Nutritional management of surgically induced menopause: A case report.
Womens Health (Lond). 2021 Jan-Dec;17:17455065211031492. doi: 10.1177/17455065211031492.
9
A double-blind placebo-controlled trial of maca root as treatment for antidepressant-induced sexual dysfunction in women.
Evid Based Complement Alternat Med. 2015;2015:949036. doi: 10.1155/2015/949036. Epub 2015 Apr 14.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验